Arrowhead Pharmaceuticals Director Sells Shares Worth $1 Million
Michael S. Perry, a director at Arrowhead Pharmaceuticals (NASDAQ:ARWR), sold 11,600 shares of the company's common stock on August 18, 2026, for approximately $1 million based on an average sale price of $87.30 per share. The transaction was disclosed via a Form 4 filing with the SEC and involved multiple trades between $87.20 and $87.44. Perry still holds over 111,000 shares directly after this sale. Arrowhead Pharmaceuticals has seen its stock price rise by 217.7% in the past year compared to an 18.8% increase for the S&P 500 index as of August 19, 2026. The company operates with a market capitalization of $12.2 billion and reported trailing twelve-month revenue of $669.5 million alongside a net loss of $320 million. The sale appears to be part of routine portfolio management by Perry rather than an indication of concern about the company's prospects, as he continues to hold a significant stake in Arrowhead Pharmaceuticals.
Tickers: $ARWR